Sunrest Lifescience Limited IPO

NSE SME

Listed On: Nov 20, 2023 at ₹ 84.0

₹ 134400 /1600 Shares

Check Allotment

Sunrest Lifescience Limited IPO Details

07 Nov, 2023

Open Date

09 Nov, 2023

Close Date

15 Nov, 2023

Allotment Date

20 Nov, 2023

Listing Date

Issue Price

₹84 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Skyline Financial Services Private Ltd

List Price

84.0

Listing Date

2023-11-20

Market Lot

1600 Shares (₹134,400/-)

Lead Manager

Mark Corporate Advisors Private Limited

Issue Size

1,291,200 shares(aggregating up to ₹10.85 Cr)

Retail Portion

50%

Subscription

48.54 times

IPO Docs

DRHP RHP

Sunrest Lifescience Limited IPO Subscription Details

As on	QIB / NII	Retail	Total
Shares Offered / Reserved	612,800	612,800	1,225,600
Day 1 - 07-11-23 06:00 PM	0.62 x	5.86 x	3.24 x
Day 2 - 08-11-23 06:00 PM	2.67 x	19.88 x	11.28 x
Day 3 - 09-11-23 06:00 PM	29.17 x	65.74 x	48.54 x

Sunrest Lifescience Limited Valuations

Earnings Per Share (EPS)

₹6.81/-

P/E Ratio

12.33

RoNW

65.59%

Net Asset Value (NAV) - Post Issue

₹N/A/-

Sunrest Lifescience Limited Company Financials All values are in ₹ Lakh

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	1,671.37	1,301.97	948.15
Revenue	2,467.05	2,690.99	1,694.91
Profit After Tax	204.31	77.71	16.55

About The Company

Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.

The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.

The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.

Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.

With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.

Sunrest Lifescience Limited - Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 69.91%

Company Promoter(s)

Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.

Sunrest Lifescience Limited IPO - Issue Objectives

Meeting Working Capital Requirements
General Corporate Purpose
Meeting Public Issue Expenses

Sunrest Lifescience Limited IPO - FAQs

Ans. Sunrest Lifescience Limited IPO is a SME IPO. The issue is priced at ₹84 per equity share. The minimum order quantity is 1600 Shares. The IPO opens on Nov 7, 2023, and closes on Nov 9, 2023. Skyline Financial Services Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Sunrest Lifescience Limited IPO opens on Nov 7, 2023 and closes on Nov 9, 2023.

Ans. The size of Sunrest Lifescience Limited IPO is 1,291,200 shares(aggregating up to ₹10.85 Cr).

Ans. The IPO price band is set between ₹84 per equity share.

Ans. To apply for Sunrest Lifescience Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Sunrest Lifescience Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Sunrest Lifescience Limited IPO is Nov 15, 2023.

Ans. The Sunrest Lifescience Limited IPO will be listed on Nov 20, 2023.

Ans. Follow the steps to check the allotment status for Sunrest Lifescience Limited IPO here.